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Abstract
Limit of detection (LOD) issues are ubiquitous in exposure assessment. While there is an 
extensive literature on modeling exposure data under such imperfect measurement processes, 
including likelihood-based methods and multiple imputation, the standard practice continues to be 
naïve single imputation by a constant (e.g. LOD ∕ 2). In this paper, we consider the situation 
where, due to the practical logistics of data accrual, sampling, and resource constraints, exposure 
data are analyzed in multiple batches where the LOD and the proportion of censored observations 
differ across batches. Compounding this problem is the potential for non-random assignment of 
samples to each batch, often driven by enrollment patterns and biosample storage. This issue is 
particularly important for binary outcome data where batches may have different levels of outcome 
enrichment. We first consider variants of existing methods to address varying LODs across 
multiple batches. We then propose a likelihood-based multiple imputation strategy to impute 
observations that are below the LOD while simultaneously accounting for differential batch 
assignment. Our simulation study shows that our proposed method has superior estimation 
properties (i.e., bias, coverage, statistical efficiency) compared to standard alternatives, provided 
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that distributional assumptions are satisfied. Additionally, in most batch assignment 
configurations, complete-case analysis can be made unbiased by including batch indicator terms in 
the analysis model, although this strategy is less efficient relative to the proposed method. We 
illustrate our method by analyzing data from a cohort study in Puerto Rico that is investigating the 
relationship between endocrine disruptor exposures and preterm birth.
Introduction
Estimating the effect of an environmental contaminant (X) on a health outcome (Y) is 
frequently affected by measurement issues related to the quantification of low concentrations 
in biologic samples. These concentration levels are often subject to a left-censoring 
mechanism called the limit of detection (LOD), which is defined as the smallest 
concentration that can be reliably distinguished from a reference with no contamination.1 
Thus far, the LOD literature has focused on one or multiple contaminants, each of which is 
uniformly subject to a single LOD across all analyzed samples.2-4 However, in large cohort 
studies, it is often not feasible to assess all concentrations in one batch and, furthermore, 
recalibration of the LOD between batches can cause the LOD to change. Moreover, samples 
are typically assayed on a rolling basis, implying that certain subject-level characteristics 
which increase the likelihood of early enrollment may be overrepresented in initial batches. 
In retrospective assaying of archived biosamples, simple storage strategies (for example, 
storing “diseased” samples in one freezer) may create different enrichment of outcomes in 
batches. Non-random assignment of samples to batches complicates matters by inducing a 
dependency between batch characteristics and the censoring mechanism itself.
The problem under consideration is motivated by an ongoing birth cohort study, The Puerto 
Rico Test site for Exploring Contamination Threats (PROTECT), which is a multi-
institutional effort to identify and understand the environmental risk factors contributing to a 
higher incidence of preterm birth in Puerto Rico, where 11.5% of live births occur 
prematurely.5 Preterm birth is the second leading cause of neonatal mortality in the United 
States and is associated with chronic respiratory complications, intestinal scarring, impaired 
cognitive development, and an elevated risk for sudden unexpected infant deaths.6-10 Urine 
samples of expecting mothers were collected at each trimester on a continuous basis but 
were analyzed in batches because of funding constraints and scientific interest in preliminary 
exposure data collection. For the present example, we focus on six of the 31 phthalate, 
phenol, paraben, and antibacterial agent concentrations that have two or more distinct LODs. 
The LOD changes were attributable to assay recalibration before analyzing each batch.
As a practitioner, it is natural to adapt existing statistical methods for handling LODs to this 
context. They can be divided into the following four broad classes: complete-case analysis, 
single imputation with a constant value, likelihood-based estimation, and multiple 
imputation. Ignoring non-detects (i.e., complete-case analysis) is usually not pragmatic, as it 
considerably reduces the number of available observations and can lead to major efficiency 
losses. Popular choices of constant imputation, such as LOD ∕ 2, LOD/2, E[X∣X < LOD], 
and E[X∣X > LOD], do not properly account for sampling variability below the LOD.
3,4,11-13
 Consequently, constant imputation results in biased parameter estimates, improperly 
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estimated standard errors, and less than nominal coverage probabilities, particularly when 
the fraction of observations below the LOD is large.4,12,14,15
Two preferred methods are to either directly obtain regression parameter estimates by 
maximizing a proper censored likelihood2,12,16-19 or to multiply impute values below the 
LOD and pool inference across imputed datasets.14,17,20-24 If distributional assumptions are 
satisfied, censored likelihood maximization has marginally better statistical efficiency 
compared to multiple imputation, but is more computationally expensive and requires a 
separate implementation for each outcome model.21 In contrast, imputing non-detects 
conditional on multiple health outcomes of interest has a major practical advantage, in that 
epidemiologic investigators can multiply impute the exposure once and use the resulting 
imputed datasets for multiple outcome models. The imputation approach is also naturally 
amenable for extension to multiple pollutants.
Sequential multiple imputation strategies, such as multiple imputation (MI) using chained 
equations, are routinely used due to their availability in standard statistical software. 
However, a straightforward implementation of MI using chained equations that ignores the 
LOD structure does not guarantee that imputed values will fall below the LOD. To ensure 
that imputed values are below the LOD, we consider censored likelihood multiple 
imputation (censored likelihood MI). The main idea behind censored likelihood MI is to 
construct a censored likelihood function derived from the conditional distribution of an 
exposure X (censored at LOD if X < LOD) given an outcome Y and a vector of covariates C 
and randomly generate samples from the fitted distribution of {X∣X < LOD, Y, C}.17,21-23 
Censored likelihood MI strategies for handling non-detects have been examined in the 
context of generalized linear models and M-regression, with potentially multiple exposures;
14,17,21,23,24
 however, little work has been done to extend these concepts to varying detection 
limits. Arunajadai et al. (2012) investigated multiple LODs, but did not consider potential 
structural bias induced by differential batch enrichment.22
The goal of this paper is to evaluate the performance of common LOD solutions under 
changing LODs and different mechanisms for sample allocation to batches. Specifically, we 
propose an extension of the censored likelihood MI strategy outlined in Lubin et al. (2004) 
for handling such data and compare this method, via extensive simulation study, to 
complete-case analysis, substitution by LOD ∕ 2, and MI using chained equations.14 We 
then apply these methods to the PROTECT dataset to assess the relationship between 
endocrine disruptor exposures and preterm birth.
Methods
We first briefly review existing methods for handling the LOD problem in exposure 
assessment, and then propose new remedies for the situation in which the LOD changes 
across batches. Let Xjl denote the true exposure for the l-th observation in batch j(j = 1, …, 
m and l = 1, …, nj), with a known distribution. For simplicity, we assume Xjl is normally 
distributed. Suppose that the underlying model for the binary outcome, Yjl, is given by
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logit(π jl) = β0 + βEX jl + βCTC jl, (1)
where πjl = P(Yjl = 1 ∣ Xjl, Cjl); Cjl = (Cjl1, Cjl2) where Cjl1 is the set of confounders, and 
Cjl2 is the set of precision variables that are correlated with Yjl but unrelated to Xjl. Our 
focus is to find a consistent estimator βE for βE and its corresponding standard error estimate 
SE(βE) when the Xjl’s are below the LOD for batch j (denoted as LODj).
Existing Methods for Analyzing Data Subject to LOD
To characterize the impact of multiple LODs, we define the underlying conceptual variable 
Zjl:
Z jl =
Z jl
obs, X jl ≥ LODj
Z jl
mis, X jl < LODj
.
That is, we assume that observations above LODj have no measurement error, i.e., 
Z jl
obs = X jl. Although this assumption may be violated in practice, the goal of this paper is to 
understand the impact of changing LODs across multiple batches on the resultant inference, 
not the joint impact of multiple LODs and exposure measurement error (which is also an 
important issue).
Complete-case analysis removes observations where Xjl < LODj and fits a logistic model on 
Z jl
obs
 only. Constant imputation replaces Z jl
mis
 with a batch-specific constant, i.e., LOD j ∕ 2, 
and fits a logistic model on Z jl
obs
 plus imputed values. Multiple imputation generates multiple 
random draws from the stochastic distribution of Z jl
mis
 conditional on Z jl
obs
, outcomes, batch 
indicators, and other covariates.
For each single or multiply imputed dataset, an estimate of the outcome-exposure 
association is then obtained by fitting a logistic regression model {Yjl∣Zjl, Cjl}. However, the 
issue of multiple batches subject to differential enrichment of disease states (and/or 
potentially important confounders) introduces a new complexity to the problem. One way to 
control for this in the analysis model is to include batch indicators such that the post-
imputation analysis model becomes,
logit(θ jl) = α0 + αEZ jl + αCTC jl + αb2I( jl ∈ Batch2) + ⋯ + αbmI( jl ∈ Batchm), (1)
where θjl = P(Yjl = 1∣Zjl, Cjl, Batchjl). For multiple imputation, the estimates are then 
pooled, properly accounting for imputation uncertainty within and between the imputed 
datasets.25-27 Going forward, we will denote the estimate of αE from analysis model (1) 
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with batch indicators as βE
WBI
 and the estimate of αE from analysis model (1) with no batch 
indicators (i.e., setting αb2 = ⋯ = αbm = 0) as βENBI, to explicitly establish the link between 
our analysis models and the true model. Both outcome models (with and without batch 
indicators) will be considered throughout the simulation study. Since our proposed 
framework is multiple imputation based on censored likelihood maximization, we will 
discuss that approach in greater detail.
Proposed Method: Censored Likelihood Multiple Imputation (censored likelihood MI)
The main goal of censored likelihood MI is to estimate the conditional cumulative 
distribution function of {Xjl∣Yjl, Cji1}, draw random values from the conditional distribution 
{Xjl∣Yjl, Cjl1, Xjl < LODj}, and fit a logistic regression on each imputed dataset. Suppose 
that {Xjl∣Yjl, Cjl1} ~ N(γ0+γ1Yjl+γTCjl1, σ2). That is, we assume the distribution of 
underlying contaminant concentrations does not depend on batch assignment. The likelihood 
can be written as:
L(γ0, γ1, γ, σ
2) ∝
∏
j = 1
m
∏
l = 1
n j
ϕX jl
(X jl ∣ Y jl,C jl1; γ0, γ1, γ, σ
2)
1 − δ(X jl)
ΦX jl
(LODj ∣ Y jl,C jl1; γ0, γ1, γ, σ
2)
δ(X jl)
where δ(Xjl) = I(Xjl < LODj) is the censoring indicator function for observation l in batch j 
and ϕXjl(·) and ΦXjl(·) are the probability density function and cumulative distribution 
function of the conditional distribution of {Xjl∣Yjl, Cjl1}. Note that it is important to 
condition on disease status (Y) in the likelihood. A likelihood ignoring Y will result in 
regression parameters biased towards the null, when a true association between Y and X 
conditional on C exists.
To obtain one imputed dataset:
i. Draw a bootstrapped dataset {Y jl∗ , X jl∗ , C ji1∗ } of the same size as the original 
dataset.
ii. Using the censored likelihood, obtain maximum-likelihood estimates γ0
∗
, γ1
∗
, γ∗, 
and σ2
∗
 for the bootstrapped dataset. The estimate of ΦXjl, ΦX jl
∗
, is the 
cumulative distribution function corresponding to a N(γ0
∗ + γ1
∗Y jl
∗ + (γ∗)TC jl1
∗ , σ2
∗
)
distribution.
iii. For every observation in the bootstrapped dataset such that X jl
∗ < LOD j, randomly 
draw q jl
∗~Unif (0, ΦX jl
∗ (LOD j)) and obtain the corresponding quantile 
Z jl
mis∗ = ΦX jl
∗ −1(q jl
∗ ).
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Repeat this procedure K times to get K imputed datasets. Pooled inference follows from 
Rubin’s combination rules.25-27
Simulation Design
We consider moderately-sized (N = 1,000) and large (N = 5,000) cohort studies, both of 
which have two distinct batches. Within each study, both batches will have three choices for 
the extent of censoring: light (15% below the LOD), moderate (30% below the LOD), and 
heavy censoring (60% below the LOD). For notational convenience, we will denote P1 and 
P2 as the percentage of observations below LOD1 and LOD2, respectively.
Generative models.—Suppose we have a contaminant of interest (X) that depends on 
two binary covariates, say smoking (S) and gender (G), such that:
{Xi ∣ Si,Gi}~N( − 0.5 + 1.25 ⋅ Si + 1.25 ⋅ Gi, 1.15
2) .
Further, suppose that the true generative model for the binary outcome is given by:
logit(πi) = − 2.68 + log(1.5) ⋅ Xi + log(1.25) ⋅ Si + log(1.25) ⋅ Gi,
where πi = P(Yi = 1∣Xi, Si, Gi). The intercept was determined by fixing the marginal 
prevalence of the outcome in the overall simulated population at P(Yi = 1) = 0.1.
Batch Assignment.—There are four assignment schemes of individuals to batches: (a) 
completely at random, (b) dependent on Y, (c) dependent only on covariates, and (d) 
dependent on both Y and covariates. The general form of the allocation model is:
logit(P(i ∈ Batch1)) = η0 + ηY ⋅ Yi + ηSSi + ηGGi
We discuss the results for scenarios (a), (b), and (c); the results for scenario (d) are expected 
to be very similar to (b). For (b), η0 = −0.13, ηY = 1.5, and ηS = ηG = 0, so that the two 
batches have an equal number of subjects and P(Batch 1 ∣Yi = 1) =0.8. As a sensitivity 
check, we also considered a modified (b) setting where P(Batch 1 ∣Yi = 1) = 0.6 (see 
eAppendix 1 for detailed results). For (c), η0 = 0.73, ηY = 0, ηS = 1.5, and ηG = −2, such 
that the two batches have an equal number of subjects and P(Batch 1 ∣Yi = 1) ≈ 0.5. That is, 
we selected coefficients in (c) such that batch assignment conditional on covariate values did 
not inadvertently introduce a dependency on outcome status. Note that the single batch 
scenario, a special case where both batches have the same LOD, can be ascertained from 
assignment scheme (a) when P1 = P2 (see eTable 1).
Using 1,000 simulated datasets, we will compare the proposed censored likelihood MI with 
complete-case analysis, constant imputation with LOD j ∕ 2 for batch j (denoted as 
LOD ∕ 2), and MI using chained equations by fitting analysis model (1) with and without 
batch indicators. Specifically, we will evaluate the methods in terms of relative bias (denoted 
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as RBıas), mean-squared error (denoted as MSE), and 95% coverage probability (denoted as 
CP) of βE
WBI
 and βE
NBI
. Explicit evaluation metric definitions are provided in eAppendix 1.
Data Example: Application to the PROTECT Cohort
The PROTECT study is a prospective cohort study in Puerto Rico that is investigating the 
relationship between exposure to environmental contaminants and preterm birth. For the 
present analysis, we are specifically interested in phthalates, phenols, parabens, and 
antibacterial agents, which are commonly found in industrial plastics, cosmetics, and 
pesticides. Exposure typically occurs through the use of personal care products, such as 
shampoos and deodorants, and the consumption of packaged food/beverages. Endocrine 
disruptors have been linked to a plethora of adverse health outcomes, including earlier onset 
of puberty, infertility, adverse birth outcomes and neurodevelopment, diabetes, and altered 
sex steroid and thyroid hormone levels.28-32 The dataset contains 1004 participants, with 31 
different contaminants measured longitudinally at three different visits, with median 
gestational age of 18, 22, and 26 weeks, respectively. Recruitment was initiated in 2010 and, 
since then, samples were shipped to the US Centers for Disease Control and Prevention 
(CDC) on a rolling basis for measurement of urinary phthalate metabolite and phenol 
concentrations by solid phase extraction high-performance liquid chromatography–isotope 
dilution tandem mass spectrometry.33 Batches were analyzed in the order that they were 
received. Because of this study protocol, a subset of contaminants had multiple LODs, six of 
which we use in our illustrative data example. Further details regarding study design and 
data collection can be found in Cantonwine et al. (2014) and Meeker et al. (2013).33,34 
Ethics and Research Committees at the University of Puerto Rico, the University of 
Michigan School of Public Health, Northeastern University, and the participating clinics 
reviewed and approved the study protocol. The involvement of the CDC laboratory was 
determined not to constitute engagement in human subjects research. The study was 
thoroughly explained to every study participant and all participating women gave informed 
consent before enrolling.
Analytic Dataset.—We consider log-transformed mono-(2-ethylhexyl) phthalate (MEHP), 
mono-(3-carboxypropyl) phthalate (MCPP), butylparaben (BPB), bisphenol F (BPF), 
triclosan (TCS), and triclocarban (TCC) measured at visits 1 and 2. Since visit 1 and visit 2 
do not necessarily contain the same subjects, we include the maximum number of subjects 
available at each visit in our analysis models. For MEHP, MCPP, BPB, and TCS, visit 1 
consists of 43 spontaneous preterm deliveries and 583 full-term deliveries, whereas visit 2 
has 42 spontaneous preterm deliveries and 598 full-term deliveries. BPF and TCC were only 
measured on a subset of subjects; therefore, visit 1 contains 31 spontaneous preterm 
deliveries and 355 full-term deliveries, while visit 2 consists of 31 spontaneous preterm 
deliveries and 351 full-term deliveries.
Statistical Analysis.—To illustrate the use of complete-case analysis, LOD ∕ 2, MI using 
chained equations, and censored likelihood MI, we fit analysis model (1) with a batch 
indicator at each visit. For the censored likelihood MI, C1 corresponds to specific gravity, 
while C2 contains maternal age, employment status, and parity. All simulations and analyses 
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were performed using R statistical software, version 3.3.1. An R implementation of the 
censored likelihood MI is available at: https://github.com/bossjona/Single-Pollutant-
Multiple-LODs.
Results
Simulation Study
Here we present results for the moderately sized study under analysis models with and 
without batch indicators. For the large study, general trends across the methods were similar, 
and hence are relegated to eTable 2, eFigure 1a, and eFigure 1b.
Random Batch Assignment.—Panels A and B in eFigure 1c present relative bias 
results, panels A and B in eFigure 1d present mean squared error (MSE) results, and Table 1 
presents the empirical coverage probabilities.
Regardless of the inclusion of a batch indicator, complete-case analysis and censored 
likelihood MI are generally unbiased across all scenarios, while LOD ∕ 2 is almost always 
biased. The resulting bias induced by LOD ∕ 2 increased as more observations became 
censored, regardless of whether a batch indicator was included. In analysis model (1) 
without a batch indicator, a naïve implementation of MI using chained equations results in 
biases when either P1 ≪ P2 or P2 ≪ P1 (e.g., RBıas(βENBI) = − 13.4%, when P1 = 60% and P2 
= 15%; eFigure 1c, panel A).
In general, MI using chained equations has the largest MSE, which is primarily driven by the 
large standard deviations associated with pooled parameter estimates. eFigure 1d shows that, 
when P1 = 60% and P2 = 60%, this method results in MSE(βE
WBI) = MSE(βE
NBI) = 0.041. In 
comparison, complete-case analysis (MSE(βE
WBI) = MSE(βE
NBI) = 0.030, LOD ∕ 2
(MSE(βE
WBI) = 0.022 and MSE(βE
NBI) = 0.021), and censored likelihood MI 
(MSE(βE
WBI) = MSE(βE
NBI) = 0.012) have smaller MSEs (see eFigure 1d). Note that complete-
case analysis still has larger MSE, because deleting observations below the LOD is 
inefficient, especially when exposure data are subject to heavy censoring. For LOD ∕ 2, the 
reduction in MSE is due to smaller variation (MSE for LOD ∕ 2 is mainly driven by the 
bias). Censored likelihood MI has a uniformly smaller MSE compared to complete-case 
analysis, MI using chained equations, and LOD ∕ 2.
In analysis model (1) with and without a batch indicator, complete-case analysis and 
censored likelihood MI have proper coverage probabilities. MI using chained equations 
occasionally has less than nominal coverage for the analysis model without a batch indicator 
when the fraction of censored observations differs across batches (for instance, when P1 = 
15% and P2 = 60%, CP(βE
NBI) = 0.922; Table 1), but has improved coverage when a batch 
indicator is included (when P1 = 15% and P2 = 60%, CP(βE
WBI) = 0.949; Table 1). LOD ∕ 2
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falls below the nominal coverage probability when P1 = P2 = 60%, whether or not a batch 
indicator is included in the analysis model (CP(βE
WBI) = 0.910, CP(βE
NBI) = 0.912; Table 1).
Outcome-Dependent Batch Assignment.—Panels A and B in Figure 1 present 
relative bias results, panels C and D in Figure 1 present MSE results, and Table 1 presents 
the empirical coverage probabilities when P(Batch 1 ∣Yi = 1) = 0.8. Results for the analysis 
model with a batch indicator were similar to the random batch assignment scenario. 
Therefore, the following discussion will focus on the analysis model without a batch 
indicator.
Under moderate and heavy censoring, complete-case analysis and MI using chained 
equations have very large biases. For example, when P1 = 15% and P2 = 60%, RBıas(βE
NBI) is 
−35.7% for CCA, while RBıas(βE
NBI) is −61.8% for MI using chained equations (see Figure 
1A). Relative biases for LOD ∕ 2 are large across all LOD pairs, however, LOD ∕ 2
outperforms CCA with respect to bias whenever P1 ≠ P2(RBıas(βE
NBI) = − 12.2%, when P1 = 
15% and P2 = 60%; Figure 1A). Censored likelihood MI leads to drastically lower relative 
biases compared with CCA, MICE, and LOD ∕ 2(RBıas(βE
NBI) = 0.6% when P1 = 15% and 
P2 = 60%; Figure 1A). Figure 1C shows that, across all (P1, P2) pairs, complete-case 
analysis and MI using chained equations have larger MSE than LOD ∕ 2 . Censored 
likelihood MI uniformly outperforms MI using chained equations, complete-case analysis, 
and LOD ∕ 2 .
Our proposed method has nominal coverage probabilities across all LOD pairs, whereas 
complete-case analysis, MI using chained equations, and LOD ∕ 2 often fall well below the 
nominal coverage probability. Notably, when P1 = 60% and P2 = 30%, the coverage 
probabilities are CP(βE
NBI) = 0.763 for complete-case analysis, CP(βE
NBI) = 0.880 for MI using 
chained equations, CP(βE
NBI) = 0.833 for LOD ∕ 2 , and CP(βE
NBI) = 0.958 for censored 
likelihood MI (see Table 1).
When P(Batch 1 ∣Yi = 1) = 0.6, the relative bias and MSE patterns are virtually identical to 
the to the P(Batch 1∣Yi = 1) = 0.8 case, the only exception being that the magnitude of the 
relative bias and MSE are smaller (see eFigures 2a and 2b).
Covariate-Dependent Batch Assignment.—Panels E and F in eFigure 1c present 
relative bias results, panels E and F in eFigure 1d present MSE results, and Table 1 presents 
the empirical coverage probabilities. Results were comparable to random batch assignment. 
Recall that the covariate-dependent batch allocation model did not introduce differential 
batch assignment by outcome, implying that outcome-dependent batch assignment is 
particularly problematic for complete-case analysis, LOD ∕ 2, and MI using chained 
equations.
Summary.—Table 2 summarizes the simulation study results presented in Figure 1, 
eFigures 1c and 1d, and Table 1. Complete-case analysis and censored likelihood MI have 
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low bias and accurate coverage probability when batch indicators are included in the 
analysis model. However, censored likelihood MI provides an efficiency gain and is the 
uniformly preferred method when more than 15% of observations fall below the LOD (in 
terms of both bias and MSE). LOD ∕ 2 and MI using chained equations are not 
recommended, as they can have large biases, improperly estimated or inflated standard 
errors, and less than nominal coverage.
PROTECT Data Analysis
At both visits 1 and 2, women that had spontaneous preterm deliveries were older on 
average, had a higher rate of unemployment, and had proportionately higher parity 
compared to women with full-term deliveries (see eTable 3). LOD summary information for 
contaminants, provided in eTable 4, shows that MEHP, MCPP, TCS, and TCC all have 
approximately 10% – 15% samples below two distinct LODs, while BPF has 51.0% below 
the LOD at visit 1 and 52.1% at visit 2 (see eFigure 3 for contaminant distributions). BPB is 
the only contaminant with four distinct LODs and has a sizable overall percent of samples 
below the LOD (37.4% at visit 1 and 43.3% at visit 2).
Table 3 shows that, as the percent of samples below LOD increased, the point estimates of 
the log-odds ratios differed more across methods, while censored likelihood MI had the 
uniformly smallest standard error and, consequently, the narrowest confidence intervals (CI). 
For BPF, the only contaminant with over 50% below the LOD in both visits 1 and 2, we 
observed that the point estimate using complete-case analysis was numerically quite 
different from the other estimates. This could be because complete-case analysis retained 
few spontaneous preterm deliveries in visit 1 and 2, making estimation of the analysis model 
unstable. One noteworthy clinical finding is that all four methods identified a significant 
association between TCC exposure and spontaneous preterm delivery at visit 1 (censored 
likelihood MI: βE = 0.254, 95% CI: 0.084, 0.425; Table 3); for a more detailed discussion 
see Aker et al. (2019).35
Discussion
In this paper, we proposed censored likelihood MI, a multiple imputation scheme to 
reconstruct the left-tail of a multiply-censored contaminant distribution such that proper 
statistical inference is made. Across a range of simulation scenarios, censored likelihood MI 
resulted in unbiased parameter estimates and correct coverage probabilities. Furthermore, 
censored likelihood MI was more efficient than other approaches such as complete-case 
analysis and MI using chained equations, evidenced by uniformly smaller standard 
deviations over all simulation settings.
When dealing with exposures assayed across multiple batches, observations may be 
unevenly assigned to batches with respect to the outcome of interest or potential 
confounders. Investigators should be mindful of the sample allocation scheme for exposure 
assays in order to minimize potential bias related to outcome enrichment. If imbalance 
occurs in batch allocation, censored likelihood MI is robust to such disparities, even when 
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there are many distinct batches (see eAppendix 2 for an additional simulation study 
exploring the robustness of censored likelihood MI to the total number of batches).
Another natural question that arises is the robustness of censored likelihood MI to 
distributional misspecification. Our simulations evaluating the impact of a misspecified 
distribution of X (X generated from a mixture of normal distributions or a gamma 
distribution) show that our method has at most an 8% relative bias across all LOD pairs (see 
eAppendix 3).
In the data example, we illustrated our method and compared the results against complete-
case analysis, LOD ∕ 2, and MI using chained equations, where each pollutant was analyzed 
separately. One promising future research direction is whether censored likelihood MI can 
be extended to the multivariate scenario where we want to model all six contaminants 
jointly. This is an important consideration, given the shift in environmental epidemiology 
towards large-scale multipollutant studies.36,37 One could easily conceptualize censored 
likelihood MI in a multipollutant setting with p contaminants by constructing a conditional 
censored likelihood under a multivariate normal distributional assumption, i.e., {Xi1, …, 
Xip∣Yi, Ci1}~MVN(μ, Σ). However, as the number of pollutants gets large, the multivariate 
normal assumption becomes tougher to satisfy and, even if it is satisfied, high-dimensional 
censored-likelihood maximization can be computationally challenging.
One theme throughout the simulation study that deserves further comment is the general 
unbiasedness of complete-case analysis, despite the LOD being a non-ignorable missing 
data mechanism. Little and Rubin (2002) claim that complete-case analysis results in 
unbiased regression parameter estimates if the probability of being a complete case depends 
only on the observed contaminant concentration and adjustment covariates (i.e., missing at 
random).13 In our simulation study, generating batch conditional on a binary health outcome 
Y implicitly introduced confounding by batch, which, when unaccounted for in the analysis 
model, biased parameter estimates obtained from complete-case analysis. It is important to 
note that complete-case analysis without batch indicators can produce biased estimates.
Conclusion
Although LOD ∕ 2 and complete-case analysis are convenient, inference can be heavily 
distorted or have low power to detect a true signal, respectively. These issues are amplified 
in the multiple batch scenario with differential batch enrichment if a batch indicator is not 
included in the analysis model. Censored likelihood MI generates efficient, unbiased 
parameter estimates when parametric assumptions are correct. It is imperative that 
researchers in environmental epidemiology understand the biases and efficiency losses of 
commonplace LOD solutions in the presence of differential batch enrichment and place a 
methodological emphasis on statistically rigorous solutions to rectify left-censored exposure 
data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Relative bias and mean-squared error (MSE) at various LOD combinations in a simulated, 
moderately-sized cohort study (N = 1,000) with outcome-dependent batch assignment 
(P(Batch 1 ∣Yi = 1) = 0.8). The first and second numbers in the LOD pair correspond to the 
percent of observations below batch 1 LOD and batch 2 LOD, respectively. Panels A and C 
correspond to an analysis model without a batch indicator and panels B and D correspond to 
an analysis model with a batch indicator. In panels A and B, the bolded black line indicates a 
relative bias of 0% (true βE = log(1.5)). In panels C and D, the bolded black line indicates 
the gold standard MSE (no observations subject to censoring).
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Abbreviations: CCA, complete-case analysis; CLMI, censored likelihood multiple 
imputation; LOD, limit of detection; MICE, multiple imputation using chained equations; 
LOD ∕ 2, constant imputation with LOD ∕ 2.
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Table 1.
Empirical Coverage Probabilities of 95% Confidence Intervals with N = 1,000.
Empirical Coverage Probability
LOD Info
With Batch Indicator (βE
WBI) Without Batch Indicator (βE
NBI)
CCA LOD ∕ 2 MICE CLMI CCA LOD ∕ 2 MICE CLMI
Random a
(15, 15) b 0.958 0.959 0.952 0.958 0.960 0.959 0.950 0.957
(15, 30) 0.953 0.957 0.957 0.956 0.957 0.957 0.956 0.954
(15, 60) 0.952 0.951 0.949 0.961 0.955 0.950 0.922 0.961
(30, 15) 0.962 0.961 0.961 0.961 0.963 0.963 0.963 0.958
(30, 30) 0.963 0.957 0.951 0.962 0.964 0.960 0.951 0.963
(30, 60) 0.959 0.942 0.953 0.962 0.955 0.945 0.946 0.963
(60, 15) 0.959 0.950 0.965 0.956 0.957 0.957 0.942 0.955
(60, 30) 0.963 0.945 0.957 0.957 0.964 0.951 0.952 0.956
(60, 60) 0.962 0.910 0.942 0.955 0.964 0.912 0.943 0.953
Outcome-Dependent c
(15, 15) 0.958 0.952 0.957 0.953 0.961 0.960 0.957 0.958
(15, 30) 0.955 0.954 0.957 0.955 0.933 0.958 0.928 0.958
(15, 60) 0.949 0.953 0.947 0.951 0.762 0.912 0.511 0.958
(30, 15) 0.953 0.948 0.945 0.954 0.935 0.956 0.931 0.953
(30, 30) 0.962 0.951 0.955 0.958 0.961 0.959 0.955 0.959
(30, 60) 0.951 0.949 0.943 0.956 0.823 0.942 0.772 0.955
(60, 15) 0.965 0.933 0.960 0.948 0.666 0.847 0.870 0.956
(60, 30) 0.958 0.929 0.965 0.956 0.763 0.833 0.880 0.958
(60, 60) 0.955 0.917 0.948 0.950 0.957 0.895 0.947 0.961
Covariate-Dependent d
(15, 15) 0.955 0.959 0.955 0.956 0.957 0.962 0.957 0.956
(15, 30) 0.956 0.965 0.957 0.956 0.961 0.964 0.957 0.957
(15, 60) 0.953 0.952 0.961 0.952 0.961 0.954 0.940 0.952
(30, 15) 0.955 0.958 0.954 0.955 0.955 0.957 0.952 0.955
(30, 30) 0.959 0.962 0.954 0.954 0.964 0.964 0.952 0.956
(30, 60) 0.957 0.943 0.963 0.962 0.958 0.949 0.958 0.962
(60, 15) 0.953 0.954 0.944 0.961 0.957 0.953 0.942 0.963
(60, 30) 0.958 0.941 0.953 0.963 0.957 0.946 0.954 0.961
(60, 60) 0.967 0.911 0.953 0.952 0.965 0.911 0.956 0.951
Abbreviations: CCA, complete-case analysis; CLMI, censored likelihood multiple imputation; LOD, limit of detection; MICE, multiple imputation 
using chained equations; LOD ∕ 2, constant imputation with LOD ∕ 2.
a
“Random” refers to random batch assignment.
b
The notation (A, B) means that approximately A% of observations in batch 1 were below the batch 1 LOD and approximately B% of observations 
in batch 2 were below the batch 2 LOD.
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c
“Outcome-Dependent” refers to batch assignment that depends on Y when P(Batch 1 ∣Yi = 1) = 0.8.
d
“Covariate-Dependent” refers to batch assignment that depends on S and G.
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Table 2.
LOD Simulation Study Properties when a Batch Indicator is Included in the Analysis Model.
% Below LOD
Method 0%-15% 15%-30% 30%-60%
CCA Absolute Rel. Bias 1.0%-1.8% 0.7%-1.8% 0.3%-3.6%
Rel. Variance a 1.2x-1.3x 1.2x-1.7x 1.3x-2.8x
MSE Ratio b 1.2x-1.3x 1.2x-1.7x 1.3x-2.8x
Coverage 95%-96% 95%-96% 94%-97%
LOD ∕ 2 Absolute Rel. Bias 2.4%-3.0% 3.1%-7.1% 4.3%-20.2%
Rel. Variance 1.0x 1.0x-1.1x 1.1x-1.4x
MSE Ratio 1.0x-1.1x 1.1x-1.5x 1.1x-4.2x
Coverage 94%-96% 91%-97% 69%-95%
MICE Absolute Rel. Bias 0.6%-1.4% 0.0%-1.8% 0.6%-7.8%
Rel. Variance 1.2x-1.4x 1.3x-1.9x 1.4x-4.1x
MSE Ratio 1.2x-1.4x 1.3x-1.9x 1.4x-4.1x
Coverage 95%-96% 95%-96% 93%-98%
CLMI Absolute Rel. Bias 0.0%-0.8% 0.1%-0.9% 0.0%-1.3%
Rel. Variance 1.0x 1.0x 1.0x
MSE Ratio 1.0x 1.0x 1.0x
Coverage 95%-96% 95%-96% 95%-96%
Abbreviations: CCA, complete-case analysis; CLMI, censored likelihood multiple imputation; LOD, limit of detection; MSE, mean-squared error; 
Rel, relative; LOD ∕ 2, constant imputation with LOD ∕ 2.
a
Relative variance is reported with respect to CLMI. As an example, relative variance ranging between 1.2x-1.3x for CCA means that, depending 
on the simulation setting, CCA is between 1.2 and 1.3 times less efficient compared to CLMI.
b
Ratio of MSEs is reported with respect to CLMI. As an example, MSE ratio ranging from 1.2x-1.3x for CCA means that, depending on the 
simulation setting, CCA has between a 1.2 and 1.3 times higher MSE compared to CLMI.
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